Recombinant human interleukin-3 truncated diphtheria toxin fusion protein | |
---|---|
Trade Name | |
Orphan Indication | Blastic plasmacytoid dendritic cell neoplasm |
EU Market Approval | EU |
EU Designation Date | 2015-11-11 00:00:00 |
Sponsor | TMC Pharma Services Ltd |